Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/03/2012WO2011155728A3 Composition for preventing or treating osteoporosis, and manufacturing method therefor
05/03/2012WO2011150320A3 Activators of innate immunity
05/03/2012WO2011144673A3 Long - acting formulations of insulins
05/03/2012WO2011139255A3 Pharmaceutical compositions comprising cefetamet
05/03/2012WO2011139254A3 Pharmaceutical formulations compising cefuroxime axetil
05/03/2012WO2011134962A3 Orally disintegrating tablet containing acarbose
05/03/2012WO2011133983A3 Reishi polysaccharide-based compositions and methods for treatment of cancer
05/03/2012WO2011133795A3 Beta-carbolines as inhibitors of haspin and dyrk kinases
05/03/2012WO2011128627A3 Oral veterinary pharmaceutical and nutraceutical compositions
05/03/2012WO2011120903A3 A fast dissolving pharmaceutical composition
05/03/2012WO2011119995A3 Formulations and methods of use
05/03/2012WO2011119227A3 Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
05/03/2012WO2011115513A9 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
05/03/2012WO2011107608A8 Heterocyclic amides as rock inhibitors
05/03/2012WO2010146348A9 Crystalline form of pemirolast
05/03/2012US20120110702 Pesticidal Compositions and Processes Related Thereto
05/03/2012US20120110683 Non-human animal model of myocardial infarction and method for creating the same
05/03/2012US20120109106 Drug delivery system for accelerated subcutaneous absorption
05/03/2012US20120109051 Devices, methods, and kits for taste modification and controlling food intake
05/03/2012US20120109044 Prevention of myocardial infraction induced ventricular expansion and remodeling
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108823 Anti-francisella agents
05/03/2012US20120108675 Process and apparatus for producing hydrocarbons by hydrogenating a terpene feed
05/03/2012US20120108674 Injectable hydrogel for the long-term supplementation of glycerol in the skin
05/03/2012US20120108673 Process for isolation of lutein and zeaxanthin crystals from plant sources
05/03/2012US20120108672 Ophthalmic composition and method for prevention of cloudiness/precipitation
05/03/2012US20120108671 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
05/03/2012US20120108670 Formoterol tartrate process and polymorph
05/03/2012US20120108669 Method of treating sleep disorders using eplivanserin
05/03/2012US20120108668 Metabolic profiles
05/03/2012US20120108667 Hydroxy ceramides and analogs thereof and their use for preventing or treating cancer
05/03/2012US20120108666 Treatment of Cell Proliferative Disorders
05/03/2012US20120108665 Methods and compositions for treating ophthalmic conditions
05/03/2012US20120108664 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
05/03/2012US20120108663 Methods of treating hypertriglyceridemia
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108660 Methods of treating hypertriglyceridemia
05/03/2012US20120108659 Methods of treating hypertriglyceridemia
05/03/2012US20120108658 Ophthalmic composition
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108656 Use of microrna-199b-5p in medical and diagnostic field
05/03/2012US20120108655 Methods of Diagnosing and Treating Carcinomas
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108653 Oligomers
05/03/2012US20120108652 Oligomers
05/03/2012US20120108651 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
05/03/2012US20120108650 Micro rna markers and methods related thereto
05/03/2012US20120108649 Methods and compositions to protect aquatic invertebrates from disease
05/03/2012US20120108648 Mitochondrial function-improving agent
05/03/2012US20120108647 Therapeutic uses of inhibitors of rtp801l
05/03/2012US20120108646 RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof
05/03/2012US20120108643 Method of increasing the extent of absorption of tizanidine
05/03/2012US20120108642 Trpv1 antagonists
05/03/2012US20120108641 Antitumor combination including ave8062 and sorafenib
05/03/2012US20120108640 Methods and compositions for the treatment of neuropsychiatric disorders
05/03/2012US20120108639 Nitrogen-containing aromatic heterocyclyl compound
05/03/2012US20120108638 Pyridin-4-yl derivatives
05/03/2012US20120108637 Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
05/03/2012US20120108636 Allosteric Enhancers of th A1 Adenosine Receptor
05/03/2012US20120108634 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
05/03/2012US20120108633 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
05/03/2012US20120108632 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
05/03/2012US20120108631 Sulfonamides for the Modulation of PKM2
05/03/2012US20120108630 Hedgehog Pathway Antagonists and Methods of Use
05/03/2012US20120108629 New use of neferine
05/03/2012US20120108628 Inhibitors of protein tyrosine kinase activity
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108626 Multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical
05/03/2012US20120108625 Novel forms of tiotropium bromide and processes for preparation thereof
05/03/2012US20120108624 Treatment of dyskinesia related disorders
05/03/2012US20120108623 Beloxepin and analogs for the treatment of pain
05/03/2012US20120108622 Pharmaceutical formulation containing gelling agent
05/03/2012US20120108621 Pharmaceutical preparation containing oxycodone and naloxone
05/03/2012US20120108620 Forms of rifaximin and uses thereof
05/03/2012US20120108619 N1/n2-lactam acetyl-coa carboxylase inhibitors
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108617 Methods and compositions involving (s)-bucindolol
05/03/2012US20120108616 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
05/03/2012US20120108615 Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108612 Inhibitors of bruton's tyrosine kinase
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/03/2012US20120108610 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/03/2012US20120108609 Dihydrooxazol-2-amine derivatives
05/03/2012US20120108608 Injectable meclizine formulations and methods
05/03/2012US20120108607 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
05/03/2012US20120108606 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108604 Processes for preparing amine salts of sildenafil-analogues and use thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108602 Carbamoyl Compounds as DGAT1 Inhibitors 190
05/03/2012US20120108601 Crystalline pyridazine compound
05/03/2012US20120108600 Substituted 4-hydroxypyrimidine-5-carboxamides
05/03/2012US20120108599 Methods and compositions for the treatment of metabolic disorders
05/03/2012US20120108598 Sitagliptin synthesis
05/03/2012US20120108597 Azaquinazolinediones Chymase Inhibitors
05/03/2012US20120108596 Aza-Bicyclic Amine N-Oxide Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligand Pro-Drugs
05/03/2012US20120108595 Platelet-activating factor receptor antagonists
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 7860